As a Free StocksGuide user, you can view scores for all 7,040 stocks worldwide.
21 Analysts have issued a Structure Therapeutics forecast:
21 Analysts have issued a Structure Therapeutics forecast:
| Jun '25 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | -219 -219 |
79%
79%
|
|
| EBIT (Operating Income) EBIT | -220 -220 |
79%
79%
|
|
| Net Profit | -179 -179 |
78%
78%
|
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company engaged in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. The company was founded by Raymond Stevens in February 2019 and is headquartered in San Francisco, CA.
| Head office | Cayman Islands |
| CEO | Raymond Stevens |
| Employees | 199 |
| Founded | 2019 |
| Website | structuretx.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


